Showing all 7 results

  • Anastrozole 1mg tablet for hormone therapy

    Anabol (Anastrozole USP 1 mg)

    0 out of 5
    Price range: $95 through $335

    Anabol (Anastrozole USP 1 mg) is an aromatase inhibitor used to manage hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which helps prevent the growth and recurrence of estrogen-dependent tumors. Anastrozole is often prescribed after surgery or radiation and is a trusted option for long-term hormonal therapy in cancer recovery protocols.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • Imatib Imatinib tablets for CML and GIST treatment

    Imatib (Imatinib)

    0 out of 5
    Price range: $265 through $925

    Imatib (Imatinib) is a tyrosine kinase inhibitor used to treat various types of cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by targeting the abnormal protein that causes cancer cells to multiply, effectively halting tumor growth. Imatib offers a highly targeted treatment approach with fewer side effects than traditional chemotherapy, making it a valuable choice for long-term cancer management.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • Imutrex Methotrexate Tablets for Rheumatoid Arthritis, Psoriasis, and Cancer Support

    Imutrex (Methotrexate)

    0 out of 5
    Price range: $105 through $240

    Imutrex (Methotrexate) is a disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis, psoriasis, and certain types of cancer. Methotrexate helps slow the progression of autoimmune disorders by reducing inflammation and suppressing the overactive immune response.

    It is widely prescribed for moderate to severe rheumatoid arthritis, severe psoriasis, and as part of chemotherapy regimens for cancers such as leukemia and lymphoma. Imutrex plays a vital role in improving joint function, reducing skin flare-ups, and controlling cell overgrowth.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • Keytruda Injection Pembrolizumab vial for cancer

    Keytruda Injection

    0 out of 5
    $8,580

    Keytruda Injection contains Pembrolizumab, a PD-1 immune checkpoint inhibitor used as an advanced immunotherapy for various cancers, including melanoma, lung cancer, head and neck cancer, and more. It works by reactivating the body’s immune system to recognize and destroy cancer cells, offering longer-lasting outcomes compared to traditional chemotherapy.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • Kisqali Ribociclib tablets for HR-positive breast cancer treatment

    Kisqali (Ribociclib)

    0 out of 5
    Price range: $1,350 through $3,550

    Kisqali (Ribociclib) is a targeted cancer therapy used in the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant. Ribociclib works by selectively inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), blocking the growth of cancer cells and slowing disease progression. It’s an FDA-approved therapy shown to extend survival in hormone receptor-positive breast cancer patients.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • Soranib 200 mg Sorafenib cancer medicine

    Soranib 200 mg (Sorafenib)

    0 out of 5
    Price range: $490 through $1,370

    Soranib 200 mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and differentiated thyroid carcinoma. It works by blocking tumor cell proliferation and blood vessel formation that feed cancer cells, slowing tumor growth and improving survival rates.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • Tagrisso 80mg Osimertinib lung cancer treatment

    Tagrisso 80mg Tablet (Osimertinib)

    0 out of 5
    Price range: $3,925 through $11,625

    Tagrisso 80mg Tablet contains Osimertinib, a third-generation EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitor) used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. It is designed to target both EGFR mutations and the T790M resistance mutation, slowing cancer progression and extending patient survival.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page

End of content

End of content